Nurse Practitioner, Family · Los Angeles, CA
NPI
1295915908
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8723 Alden Dr. Suite 215
Los Angeles, CA, 90048
Phone (310) 423-1246
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,247
81 services
Medicare patients, 2024
50
Average age 72
Drug cost, 2024
$467K
895 prescriptions
Company payments, 2025
$3,711
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Coka K Yip was code 99215 (office e&m - established), 40 times for 31 patients. In total Coka K Yip billed 81 services in 5 codes, and Medicare paid $6,247.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 40 | 31 | $94.96 | $3,798 |
| 99214 Office E&M - Established | Facility | 20 | 16 | $70.86 | $1,417 |
By year: 2022 $9,063 for 125 services; 2023 $8,668 for 112 services; 2024 $6,247 for 81 services.
Medicare prescription drug claims, 2024
In 2024, the drug Coka K Yip prescribed most often to Medicare patients was Motegrity (Prucalopride Succinate), with 171 prescriptions and refills. In total Coka K Yip wrote 895 Medicare prescriptions that cost $467K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Motegrity Prucalopride Succinate | 171 | 273 | 41 | $142K |
| Xifaxan Rifaximin | 58 | 58 | 24 | $144K |
| Famotidine Generic | 53 | 109 | 17 | $1,156 |
| Pantoprazole Sodium Generic | 43 | 109 | 15 | $647 |
| Linzess Linaclotide | 39 | 63 | 17 | $33K |
| Lubiprostone Generic | 39 | 69 | 14 | $8,638 |
| Omeprazole Generic | 38 | 66 | Under 11 | $401 |
| Esomeprazole Magnesium Generic | 37 | 83 | Under 11 | $4,161 |
| Erythromycin Erythromycin Base | 35 | 70 | 15 | $3,660 |
| Movantik Naloxegol Oxalate | 33 | 47 | Under 11 | $19K |
| Trulance Plecanatide | 33 | 54 | 11 | $29K |
| Ondansetron Hcl Generic | 22 | 40 | Under 11 | $714 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 19 | 19 | Under 11 | $735 |
| Pyridostigmine Bromide Generic | 18 | 43 | Under 11 | $1,448 |
| Ondansetron Odt Ondansetron | 17 | 17 | Under 11 | $836 |
Brand drugs: 444 claims; generic drugs: 451 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Coka K Yip $3,711 ($3,711 in general payments such as food, travel and fees) from 5 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $3,438.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.